Pharma: Developing lentiviral vectors for <i>ex vivo</i> and <i>in vivo</i> gene therapy

Already Registered?

If you have previously registered for this event, please login below:

By registering your details, you agree to our Terms & Conditions and Privacy Policy and acknowledge that Progressive Media International Ltd may share your information with the commercial partners/sponsors of this webinar who may contact you directly with information on their products and services.

Visit our privacy policy for more information about our services, how we may use and process your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Developing lentiviral vectors for ex vivo and in vivo gene therapy

Date: 17 November | Time: 2PM London / 3PM CET

Watch Now for FREE ON24

Developing lentiviral vectors for ex vivo and in vivo gene therapy

Date: 17 November | Time: 2PM London / 3PM CET

Already Registered?

Optimizing vector design for improved quality and safety

Presented by

,

Key Learning Objectives

Audience

Developing lentiviral vectors for ex vivo and in vivo gene therapy Date: 17 November | Time: 2PM London / 3PM CET Watch Now for FREE ON24

Developing lentiviral vectors for ex vivo and in vivo gene therapy

Date: 17 November | Time: 2PM London / 3PM CET

Already Registered?

Optimizing vector design for improved quality and safety

Presented by

,

Key Learning Objectives

Audience

Developing lentiviral vectors for ex vivo and in vivo gene therapy

Date: 17 November | Time: 2PM London / 3PM CET

Watch Now for FREE ON24